Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
July 28, 2025
Fully automated 3D multi-modal deep learning model for preoperative T-stage prediction of colorectal cancer using <sup>18</sup>F-FDG PET/CT
Mobei Zhang, Yufan Li, Chunhong Zheng, et al.
Molecular Pharmaceutics
|
December 17, 2025
Preclinical and Initial Clinical Evaluation of <sup>68</sup>Ga/<sup>177</sup>Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin α<sub>V</sub>β<sub>3</sub>
Linlin Li, Xingtong Peng, Jialin Xiang, et al.
Journal of Ethnopharmacology
|
October 2, 2023
Shuyu decoction exhibits anti-fatigue properties via alleviating exercise-induced immune dysfunction
Shujing Zhang, Yuemeng Sun, Jiarou Wang, et al.
Clinical Nuclear Medicine
|
May 5, 2025
Bisphosphonate Bone Imaging Agent [68Ga]Ga-P15-041 for Evaluating Skeletal Metastases in Prostate Cancer: A Comparison With [68Ga]Ga-PSMA-11 PET/CT
Jiarou Wang, Linlin Li, Tianrui Feng, et al.
Journal of Ethnopharmacology
|
March 27, 2025
Corrigendum to "Shuyu decoction exhibits anti-fatigue properties via alleviating exercise-induced immune dysfunction" [J. Ethnopharmacol. 319 (2024) Part 2 117259]
Shujing Zhang, Yuemeng Sun, Jiarou Wang, et al.
World Journal of Urology
|
January 12, 2024
Comparisons of mpMRI, <sup>68</sup>Ga-PSMA PET/CT and mpMRI combined with <sup>68</sup>Ga-PSMA PET/CT in diagnosing prostate cancer based on tumor detection, localization and staging
Zhipeng Mai, Ming Zhu, Tianrui Feng, et al.
Theranostics
|
June 7, 2023
Dual targeting PET tracer [
Rongxi Wang, Vivianne Jakobsson, Jiarou Wang, et al.
Acta Pharmaceutica Sinica. B
|
April 3, 2025
Safety, pharmacokinetics, and dosimetry of <sup>177</sup>Lu-AB-3PRGD2 in patients with advanced integrin <i>α</i> <sub>v</sub> <i>β</i> <sub>3</sub>-positive tumors: A first-in-human study
Huimin Sui, Feng Guo, Hongfei Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 24, 2024
Head-to-Head Comparison of [<sup>68</sup>Ga]Ga-NOTA-RM26 and [<sup>18</sup>F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study
Rongxi Wang, Weiming Kang, Zhen Liu, et al.
Clinical Nuclear Medicine
|
April 6, 2026
Dual-targeted 68Ga-NOTA-3P-TATE-RGD PET/CT in Radioactive-iodine Negative Differentiated Thyroid Cancer: An Exploratory Comparative Study With 18F-FDG
Jialin Xiang, Yanwei Wang, Xin Zhang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
European Journal of Nuclear Medicine and Molecular Imaging
|
July 28, 2025
Fully automated 3D multi-modal deep learning model for preoperative T-stage prediction of colorectal cancer using <sup>18</sup>F-FDG PET/CT
Mobei Zhang, Yufan Li, Chunhong Zheng, et al.
Molecular Pharmaceutics
|
December 17, 2025
Preclinical and Initial Clinical Evaluation of <sup>68</sup>Ga/<sup>177</sup>Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin α<sub>V</sub>β<sub>3</sub>
Linlin Li, Xingtong Peng, Jialin Xiang, et al.
Journal of Ethnopharmacology
|
October 2, 2023
Shuyu decoction exhibits anti-fatigue properties via alleviating exercise-induced immune dysfunction
Shujing Zhang, Yuemeng Sun, Jiarou Wang, et al.
Clinical Nuclear Medicine
|
May 5, 2025
Bisphosphonate Bone Imaging Agent [68Ga]Ga-P15-041 for Evaluating Skeletal Metastases in Prostate Cancer: A Comparison With [68Ga]Ga-PSMA-11 PET/CT
Jiarou Wang, Linlin Li, Tianrui Feng, et al.
Journal of Ethnopharmacology
|
March 27, 2025
Corrigendum to "Shuyu decoction exhibits anti-fatigue properties via alleviating exercise-induced immune dysfunction" [J. Ethnopharmacol. 319 (2024) Part 2 117259]
Shujing Zhang, Yuemeng Sun, Jiarou Wang, et al.
World Journal of Urology
|
January 12, 2024
Comparisons of mpMRI, <sup>68</sup>Ga-PSMA PET/CT and mpMRI combined with <sup>68</sup>Ga-PSMA PET/CT in diagnosing prostate cancer based on tumor detection, localization and staging
Zhipeng Mai, Ming Zhu, Tianrui Feng, et al.
Theranostics
|
June 7, 2023
Dual targeting PET tracer [
Rongxi Wang, Vivianne Jakobsson, Jiarou Wang, et al.
Acta Pharmaceutica Sinica. B
|
April 3, 2025
Safety, pharmacokinetics, and dosimetry of <sup>177</sup>Lu-AB-3PRGD2 in patients with advanced integrin <i>α</i> <sub>v</sub> <i>β</i> <sub>3</sub>-positive tumors: A first-in-human study
Huimin Sui, Feng Guo, Hongfei Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 24, 2024
Head-to-Head Comparison of [<sup>68</sup>Ga]Ga-NOTA-RM26 and [<sup>18</sup>F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study
Rongxi Wang, Weiming Kang, Zhen Liu, et al.
Clinical Nuclear Medicine
|
April 6, 2026
Dual-targeted 68Ga-NOTA-3P-TATE-RGD PET/CT in Radioactive-iodine Negative Differentiated Thyroid Cancer: An Exploratory Comparative Study With 18F-FDG
Jialin Xiang, Yanwei Wang, Xin Zhang, et al.
Page
of 4